| CXSB2101038 | 注射用重组人肿瘤坏死因子相关凋亡诱导配体–三聚体融合蛋白 | | Lyophilized | Biological Products(1) | Supplementary Application | 2021-09-02 | | Sichuan Clover Biopharmaceuticals Co Ltd | | | view |
| CXSL2000185 | 注射用重组人肿瘤坏死因子相关凋亡诱导配体–三聚体融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2020-07-04 | 四川三叶草生物制药有限公司 | Sichuan Clover Biopharmaceuticals Co Ltd | In Review | 2020-07-02 | view |
| CXSL2000184 | 注射用重组人肿瘤坏死因子相关凋亡诱导配体–三聚体融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2020-07-01 | 四川三叶草生物制药有限公司 | Sichuan Clover Biopharmaceuticals Co Ltd | In Review | 2020-06-29 | view |
| CXSL1900034 | 注射用重组人肿瘤坏死因子相关凋亡诱导配体–三聚体融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2019-04-19 | 四川三叶草生物制药有限公司 | Sichuan Clover Biopharmaceuticals Co Ltd | In Review | 2019-04-18 | view |
| CXSL1900031 | 注射用重组人肿瘤坏死因子相关凋亡诱导配体–三聚体融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2019-04-01 | 四川三叶草生物制药有限公司 | Sichuan Clover Biopharmaceuticals Co Ltd | In Review | 2019-03-29 | view |
| CXSL1900015 | 注射用重组人肿瘤坏死因子相关凋亡诱导配体–三聚体融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2019-02-22 | 四川三叶草生物制药有限公司 | Sichuan Clover Biopharmaceuticals Co Ltd | In Review | 2019-02-21 | view |
| CXSB1400014 | 注射用重组人肿瘤坏死因子相关凋亡诱导配体 | | Lyophilized | Biological Products | Supplementary Application | 2015-01-14 | 深圳新鹏生物工程有限公司 | Shenzhen Sinobioway Xinpeng Biomedicine Co Ltd | Certificate Issued | 2015-09-08 | view |
| CXSL1200019 | 注射用重组人肿瘤坏死因子相关凋亡诱导配体 | | Lyophilized | Biological Products(1) | New Drug Application | 2012-06-19 | 浙江海正药业股份有限公司 | Zhejiang Hisun Pharmaceutical Co Ltd | Certificate Issued | 2013-08-09 | view |
| CXSL0800014 | 注射用重组人肿瘤坏死因子相关凋亡诱导配体 | | Lyophilized | Biological Products(1) | New Drug Application | 2008-05-23 | 深圳新鹏生物工程有限公司 | Shenzhen Sinobioway Xinpeng Biomedicine Co Ltd | Certificate Issued | 2010-04-19 | view |
